Medchem Partners LLC
Lexington, MA
- UEI
- S93ZFQLD4ZC7
- CAGE
- 4KJ97
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 99 Hayden Ave #210, Lexington, MA 02421, USA
- Website
- medchempartners.com
- Founded
- 2006
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- Research & Consulting Services
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Kevirx Inc. | Charlottesville, VA | — |
| Adepthera LLC | Palo Alto, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Covenant Therapeutics LLC | Charlottesville, VA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Microcures Inc. | NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Advac Therapeutic LLC | Philadelphia, PA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
About the company
Medchem Partners LLC is a woman-owned small business that specializes in developing novel therapeutic compounds for medical applications. Registered with the federal government since 2006, this partnership or limited liability partnership focuses on advancing innovative drug therapies through research and development. Medchem Partners has received multiple federal grant awards to support its work in creating new treatments for ocular and pulmonary conditions, demonstrating expertise in medicinal chemistry and drug discovery.
The company's federal grant awards have primarily come from the National Eye Institute and the National Science Foundation's Division of Industrial Innovation. Medchem Partners has received funding to develop dynasore analogues for ocular surface protection and to combat corneal herpes simplex virus (HSV) infection. Their work includes refining the structure-activity relationship of compounds to inhibit HSV infection and subsequent inflammation in the cornea, with the goal of identifying lead compounds for further development. The company has also been awarded grants to create novel inhaled nitric oxide therapies for pulmonary treatments, particularly in relation to COVID-19. These projects align with federal grant programs focused on vision research and engineering innovations to improve quality of life and economic strength. Through these awards, Medchem Partners contributes to addressing significant public health challenges, such as HSV-related ocular infections and lung conditions exacerbated by COVID-19.
Quick answers
Is Medchem Partners LLC registered in SAM.gov?
Yes. Medchem Partners LLC's SAM.gov registration is active through November 11, 2026.
What is Medchem Partners LLC's CAGE code?
Medchem Partners LLC's CAGE code is 4KJ97, and its Unique Entity ID (UEI) is S93ZFQLD4ZC7.
What is Medchem Partners LLC's most recent federal award?
Medchem Partners LLC's most recent federal grant award is Combating corneal HSV infection with novel dynasore analogues (R41EY035879), from National Eye Institute (NIH), on February 1, 2024.
On GovTribe
See Medchem Partners LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors